Live · 18 Sep 2026 SPX 7,637.76 +1.14% NDX 29,446.98 +1.73% VIX 15.48 +0.26% GOLD 4,411.60 +0.27% CL 96.45 -5.36% BTC 77,964.98 +2.04%
NAS100 29,447 +1.73% S&P 7,638 +1.14% GOLD $4,412 +0.27% BTC $77,965 +2.04% VIX 15.48 +0.26% live tape · as of 17:00 UTC
The Screen · Industrials · Engineering & Construction

Argan, Inc. logoArgan, Inc.

AGX · the NYSE · USD · Market cap $5.8B · 1,409 employees

Argan, Inc., through its subsidiaries, provides engineering, procurement, construction, commissioning, maintenance, project development, and technical consulting services to the power generation market in the United Stat…

FAIL · Does not pass the screen
413.74 USD

At the last full screen
2026-09-11

Screened 2026-09-11 · the tape above runs as of 17:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

The Label · The Season, Not the Day

This name holds its markdown label.

Argan, Inc. holds its Markdown at $413.74. The statistical read favours the sellers, held for 10 days.

As held on the ledger · 2026-09-11
PhaseMarkdown · caution
Quantitative stateThe statistical read favours the sellers, held for 10 days
Price at the screen$413.74
Valuation32.73 trailing · 25.49 forward price to earnings
Values screenFAIL · score 70.0
Beta0.57
The Workings

Five Screens, Shown in Full

Does not pass. Interest-bearing securities

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 0.21% Below 33% Interest-bearing debt is just 0.2% of its assets, well under the one-third ceiling: it does not run on borrowed money. Pass
Interest-bearing cash 46.82% Below 33% Interest-bearing cash and securities are 46.8% of assets, above the one-third limit. Fail
Receivables 39.88% Below 49% Money owed to the company is 39.9% of assets, under the 49% limit. Pass
Revenue purity 0.00% Below 5% Only 0.0% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

What the Numbers Say It Is Worth

The Fair Value Range

245.70Conservative453.55Base case521.58Growth case 413.74Price

Fair value range in USD, drawn from the 2026-09-11 screen. The gold marker is the market price at the same screen. A 9.6% margin of safety to the base estimate.

The Street's Range
273.00Street low 582.50Street average 800.00Street high 413.74Price

Third-party analyst targets: 6 covering, consensus Buy. The average target sits +41% from the screen price.

Reading the gap · Both our model and the analysts see meaningful upside from here.

Price History & Projections
$861$418$-24TODAY5y agoPROJECTIONStreet high$800.00 +35%Street avg$582.50 -2%Our fair value$453.55 -23%Conservative$245.70 -59%

Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-11 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Power builder races ahead of our fair value

Every time a grid needs a new gas plant or data centre backup, Argan steps in to design and deliver it. The numbers look strong on paper, with revenue jumping 50 percent and return on equity at 39 percent. Yet the shares sit 7 percent above our calculated worth at a forward multiple of 33.9 times, leaving no margin of safety and an opportunity rating of none.

The business clears our ethical screen cleanly and shows solid 15 percent profit margins. Five analysts still cluster around a 700 dollar median target. We see the same operating strength but cannot ignore the gap between price and our 512 dollar fair value.

Construction work remains lumpy and exposed to energy project cycles, while the moat stays unknown. High multiples can compress quickly when orders slow. Analysis, not advice.

The fundamentals · plain-English read
Forward P/E25.5xcheap for a company growing this fast
Trailing P/E32.7xa premium valuation
EPS, trailing12.64
EPS, forward16.23
Revenue growth+61.5%growing very fast
Profit margin15.1%healthy profit margins
Return on equity39.8%an exceptional return on shareholder capital
FCF yield8.06%
Dividend yield31.00%
Debt to equity2.15heavy leverage: higher risk if revenue softens
Current ratio1.50healthy short-term liquidity
Beta0.57steadier than the market
Short interest, float0.08%
52-week range227.79 - 805.75
Market cap$5.8B
Employees1,409

The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

AGX trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-09-02 Markdown $450.46 +0.0% Entry 14

The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 71% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 184%. Our forward projection puts the odds of a 10% gain over the next month near 53%. The street (5 analysts) rates it none, with a mean price target of $473. It reported earnings in this window, a natural checkpoint for the thesis.

2026-09-01 Markdown $450.46 +0.0% Entry 13

The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 71% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 184%. Our forward projection puts the odds of a 10% gain over the next month near 53%. The street (5 analysts) rates it none, with a mean price target of $473. It reported earnings in this window, a natural checkpoint for the thesis.

2026-08-31 Markdown $450.46 +0.0% Entry 12

The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 71% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 184%. Our forward projection puts the odds of a 10% gain over the next month near 53%. The street (5 analysts) rates it none, with a mean price target of $473. It reported earnings in this window, a natural checkpoint for the thesis.

2026-08-30 Markdown $450.46 +0.0% Entry 11

The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 71% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 184%. Our forward projection puts the odds of a 10% gain over the next month near 53%. The street (5 analysts) rates it none, with a mean price target of $473. It reported earnings in this window, a natural checkpoint for the thesis.

2026-08-29 Markdown · changed $450.46 +0.0% Entry 10

The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 71% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 184%. Our forward projection puts the odds of a 10% gain over the next month near 53%. The street (5 analysts) rates it none, with a mean price target of $473. It reported earnings in this window, a natural checkpoint for the thesis.

2026-08-28 Distribution $450.46 +0.0% Entry 9

The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 71% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 184%. Our forward projection puts the odds of a 10% gain over the next month near 53%. The street (5 analysts) rates it none, with a mean price target of $473. It reported earnings in this window, a natural checkpoint for the thesis.

2026-08-27 Distribution $450.46 +0.0% Entry 8

The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 71% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 184%. Our forward projection puts the odds of a 10% gain over the next month near 53%. The street (5 analysts) rates it none, with a mean price target of $473. It reported earnings in this window, a natural checkpoint for the thesis.

2026-08-26 Distribution $450.46 -23.8% Entry 7

The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 23.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 71% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 184%. Our forward projection puts the odds of a 10% gain over the next month near 53%. The street (5 analysts) rates it none, with a mean price target of $473. It reported earnings in this window, a natural checkpoint for the thesis.

2026-08-21 Distribution · changed $590.87 +7.2% Entry 6

The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 7.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 71% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 184%. Our forward projection puts the odds of a 10% gain over the next month near 53%. The street (5 analysts) rates it none, with a mean price target of $473.

2026-07-20 Accumulation $551.26 -14.1% Entry 5

The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 14.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 71% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 184%. Our forward projection puts the odds of a 10% gain over the next month near 53%. The street (5 analysts) rates it none, with a mean price target of $473.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Related Securities · Others in AGX's Space

Screened names in the same industry · explore each on its own page.

The Political Ledger · Congressional Disclosures
Disclosures naming AGX
DatePoliticianPartyTypeAmount
2026-06-30 Gil Cisneros Democrat buy 15K–50K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $683.52 -13.4% · $867 -13.4%
2 months $603.35 -1.8% $0.50 $982 -1.8%
3 months $458.93 +29.1% $0.50 $1,292 +29.2%
6 months $329.92 +79.5% $1.00 $1,798 +79.8%
1 year $208.25 +184.4% $1.88 $2,853 +185.3%
2 years $76.16 +677.6% $3.30 $7,820 +682.0%
3 years $36.61 +1,517.6% $4.45 $16,298 +1,529.8%
5 years $43.69 +1,255.6% $6.45 $13,704 +1,270.4%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever AGX does next, these words stay.

Argan, Inc. · AGX · Markdown · $413.74
Recorded 2026-09-11 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.